Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG)
Ritika Sharma
a,
Anchala Kumarib,
Bishwajit Kunduc and
Abhinav Grover*a
aSchool of Biotechnology, Jawaharlal Nehru University, New Delhi-110067, India. E-mail: sharma.ritika198@gmail.com; abhinavgr@gmail.com; Tel: +91-8130738032
bIndian Council of Medical Research, International Health Division, New Delhi-110029, India. E-mail: anchala.choudhary27@gmail.com
cKusuma School of Biological Sciences, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, India – 110016. E-mail: bkundu@bioschool.iitd.ac.in
First published on 23rd December 2022
Abstract
Correction for ‘Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG)’ by Ritika Sharma et al., RSC Adv., 2022, 12, 29469–29481, https://doi.org/10.1039/D2RA05061G.
In the original article, in Section 4.11 REMD simulations, the number of replicas, their average exchange probability and the temperature range utilized were inaccurately reported as 32, 20% and 290–500 K, respectively. However, the presented results were obtained using 48 replicas, with an average exchange probability of 13% and a temperature range of 298–380 K. The authors regret this error. The scientific conclusions of this article remain unchanged.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |